Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A4ea1bbe-121a-4b94-bf51-ad6059838c03 - samples

ABSTRACT: Shotgun sequencing data from subject as baseline and after 4 weeks of daily doses of low, medium or high CFU Eubacterium hallii L2-7. The strain contained in the drink "Ela" was also sequenced.

PROVIDER: EGAD00001004849 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Comparative transcriptomic profiling of breast-milk isolated total somatic cells from women with mastitis following the consumption of a probiotic containing a Lactobacillus salivarius PS2 strain

Project description:We used Affymetrix microarrays to investigate gene expression changes in somatic cells from breast-milk extracted from women suffering from mastitis and taking a daily dose of three capsules with ~50 mg of a freeze-dried probiotic (~109 CFU of L. salivarius PS2 strain) for 21 days. Healthy women were subjected to the same treatment for comparison.

2015-01-21 | GSE65152 | GEO

Transcription profiling of Density-dependent of Xanthomonas oryzae pv. oryzae PXO99A and PXO99∆ax21

Project description:Xanthomonas oryzae pv. oryzae strain PXO99A, so called Xoo, is disable to infect in rice cultivar carrying Xa21 gene. A set of experiments indicated that Ax21 is quorum sensing factor in PXO99 strain. To observe fine-tuned details how Ax21 controls expression of PXO99 in response to change of cell population density, transcriptional profiling analysis was perform by using published two channel oligo Xo microarray platform (Seo et al.,2008 BMC microbiology). Keywords: Comparative transcription profiling between low cell density and high cell density with same genetic background Three biological and dye-swap replicates, total six samples for each dataset. Two datasets contained; (i) PXO99 at 106 CFU/ml vs 108 CFU/ml, and (ii) PXO99∆ax21at 106 CFU/ml vs PXO99∆ax21 108 CFU/ml. 106 CFU/ml and 108 CFU/ml are cell density used in this study as representation of low and high cell density. All bacteria cultures were grown in PS (Peptone sucrose) broth media.

2012-01-01 | E-GEOD-24989 | biostudies-arrayexpress

Humoral Immune response of Galleria mellonella to BCG and APP

Project description:The humoral immune response of Galleria mellonella exposed to Mycobacterium bovis BCG (vaccine strain), 1x107 CFU (10 ul inoculum) were injected into the larvae. For low dose BCG challenge, 1x105 CFU (10 ul) were injected. For larval challenge with Actinobacillus pleuropneumoniae (APP), ~1.5x106 CFU (10 ul) were injected. APP were only challenged at this single dose. For larval challenge with Control (0h) were included. APP and low dose (1x105 CFU) BCG were sampled only at 48 h post infection.

2021-09-08 | PXD015250 | Pride

Root exudate metabolomics data for Brachypodium distachyon in fabricated ecosystems (EcoFAB 2.0)

Project description:Root exudate LC-MS data for Brachypodium distachyon Bd21-3 grown for 5 weeks on different iN+ media (groups: +NH4, +NO3, +NH4NO3) or 3 weeks in iN+ medium followed by two weeks on iN-free medium (groups: -NH4, -NO3, -NH4NO3). Each treatment had 5 biological replicates. The iN+ media contained inorganic N (iN) at 5 mM. Plants were grown inside EcoFAB 2.0 Method details can be found here: doi: https://doi.org/10.1101/2023.01.18.524647

2023-05-30 | MSV000092053 | MassIVE

Phase 1 clinical trial evaluating whether probiotic supplementation prevents chemotherapy-induced diarrhoea and other intestinal adverse effects in cancer patients.

Project description:Intervention: MultiBiotic probiotic formulation containing per capsule: Lactobacillus rhamnosus (Med 26)9 billion CFU Lactobacillus acidophilus (Med 27)3.75 billion CFU Lactobacillus plantarum (Med 25)1.575 billion CFU Bifidobacterium animalis spp. lactis (Med 13)3 billion CFU Bifidobacterium breve (Med 12)1.75 billion CFU Bifidobacterium bifidum (Med 11)500 million CFU Streptococcus thermophilus (Med 51)1.5 billion CFU Total21.075 Billion CFU* / 1 capsule Dosage: 2 capsules twice daily. Mode of administration: oral Duration of intervention: 12 weeks Monitoring: Drug bottles returned (empty or not) to trial investigator. Primary outcome(s): A composite primary outcome of physical, social, emotional and functional well-being (33 items) will be evaluated according to the FACT-C scale. The primary outcome will be the mean change in the FACT C total score (33-item) between baseline and end of of the study (12 weeks). [Participants Research Diary collected at the end of the study (12 weeks)];Mean change in Bristol Stool scores between baseline and end of the study (12 weeks).[Participants Research Diary collected at the end of the study (12 weeks)];Mean changes in blood lipopolysaccharide between baseline and end of three chemotherapy cycles.[Blood drawn at baseline and the end of the study (12 weeks).] Study Design: Purpose: Prevention; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group;Type of endpoint: Safety/efficacy

| 2467327 | ecrin-mdr-crc

Glycogen Accumulation in Chlamydia trachomatis is Controlled by its Plasmid Through Regulation of glgA

Project description:C. trachomatis possess a cryptic 7.5 kb plasmid of unknown function. Here we describe a comprehensive molecular and biological characterization of the naturally occurring plasmidless human Chlamydia trachomatis strain L2 (25667R). We found that despite minimal chromosomal polymorphisms the LGV L2 (25667R) strain was indistinguishable from the L2 (434) plasmid positive strain in its in vitro infectivity characteristics such as growth kinetics, plaquing efficiency, and plaque size. The primary in vitro phenotypic differences between L2 (434) and L2 (25667R) were the accumulation of glycogen granules in the inclusion matrix and the lack of the typical intra-inclusion Brownian-like movement characteristic of C. trachomatis strains. Conversely, we observed a marked difference between the two strains in their ability to colonize and infect the female mouse genital tract. The ID50 of the L2 (25667R) plasmidless strain was 500 fold greater (1.XX x 10X IFU) than the L2 (434) plasmid bearing strain (1. XX x 10X IFU). Transcriptome analysis of the two strains clearly demonstrated a decrease in transcript levels of a subset of chromosomal genes for the L2 (25667R) strain. Among those genes was glgA which encodes for glycogen synthase; a finding consistent with the failure of the L2 (25667R) strain to accumulate glycogen granules. Collectively, these findings support an important role for the plasmid in in vivo infectivity and suggest that this virulence characteristic might be controlled by the plasmids ability to regulate the expression of specific chromosomal genes. These results also support an important role for the plasmid in the pathogenesis of human infection and disease. Keywords: strain comparison

2009-01-15 | GSE10199 | GEO

Comprehensive single cell transcriptional profiling of a multicellular organism by combinatorial indexing

Project description:We developed a combinatorial indexing strategy to profile the transcriptomes of large numbers of single cells or nuclei (Single cell Combinatorial Indexing RNA-seq or sci-RNA-seq). We applied sci-RNA-seq to profile nearly 50,000 cells from C. elegans at the L2 stage, effectively ~56-fold “shotgun cellular coverage” of its somatic cell composition.

2017-08-17 | GSE98561 | GEO

Effect of probiotics on colorectal cancer in clinical trials

Project description:Interventions: Ten subjects receive probiotic product contained 10 million CFU in viable form 3 times a day for 6 months,Ten subjects receive probiotic product contained 10 million CFU in non viable form 3 times a day for 6 months, Ten subjects receive product without probiotic 3 times a day for 6 months;Active Comparator Dietary Supplement,Active Comparator Dietary Supplement,Placebo Comparator Dietary Supplement;probiotic products in viable form,probiotic products in non viable form,Control Primary outcome(s): reduceing of number of pathogens in gut at 6 months after intervention number of pathogens / Anova Study Design: Randomized

| 2727906 | ecrin-mdr-crc

Bifidobacterium bifidum PRL2010 actively changes the expression profiles of mouse

Project description:We studied the global transcription profiling of mouse upon colonization with Bifidobacterium bifidum PRL2010 by using DNA microarrays. Two groups of mice consisting each of two animals were orally inoculated with either 109 CFU of PRL2010 cells (test strain) or water (control). Animals were 3 months old female BALB/c mice. Bacterial colonization was established by five consecutive daily administrations using a micropipette tip placed immediately behind the incisors.

2013-11-19 | E-GEOD-48495 | biostudies-arrayexpress

gene expression of ventral prostate in rat

Project description:Gene expression microarray analysis was performed on ventral prostate from normal adult rats, and adult rats treated BPA for 4 weeks(10 animals per group). Animals of 4 groups were treated with bisphenol-A (0,10, 30, or 90 ug/kg, i.g., daily) for 4 weeks, and the dosing volume is 10 ml/kg body weight. In this experiment, we only selected samples from two doses(0 and 10µg/kg) to analyze.

2014-01-15 | E-MTAB-2181 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data